Sort
10,766 grants matching “checkpoint inhibitor”
p38 MAP kinase in early thymocyte development
$368,763Mercedes R. Rincon · University Of Vermont & St Agric College · R01 · FY2012 · AI
p38 MAP kinase in early thymocyte development
$368,763Mercedes R. Rincon · University Of Vermont & St Agric College · R01 · FY2011 · AI
Quinolinate-induced immune suppression in glioblastoma
$368,600Prakash Chinnaiyan · William Beaumont Hospital Research Inst · R01 · FY2024 · NS
Immunogenic Priming with Lu-PSMA Targeted Therapy in Advanced Prostate Cancer
$368,455Rahul Aggarwal · University Of California, San Francisco · R01 · FY2020 · CA
Project 3: Modulation of the head and neck tumor immune microenvironment by targeting the TAM family of receptors
$368,400Deric L Wheeler · University Of Wisconsin-Madison · P50 · FY2024 · CA
Determinants of prostate cancer sensitivity to PD-1 blockade
$368,288Lawrence Fong · University Of California, San Francisco · R01 · FY2021 · CA
Regulation of antigen presenting cells in the tumor microenvironment by retinoic acid
$368,288Malay Haldar · University Of Pennsylvania · R37 · FY2022 · CA
A novel more effective genotoxic therapy for ovarian cancer
$368,288Fiona Simpkins · University Of Pennsylvania · R37 · FY2022 · CA
Macrophage-based Therapy and Immune Checkpoint Blockade for Glioblastoma
$368,288Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · CA
Macrophage-based Therapy and Immune Checkpoint Blockade for Glioblastoma
$368,288Shideng Bao · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · CA
Regulation of antigen presenting cells in the tumor microenvironment by retinoic acid
$368,288Malay Haldar · University Of Pennsylvania · R37 · FY2020 · CA
Regulation of antigen presenting cells in the tumor microenvironment by retinoic acid
$368,288Malay Haldar · University Of Pennsylvania · R37 · FY2021 · CA
Regulation of antigen presenting cells in the tumor microenvironment by retinoic acid
$368,288Malay Haldar · University Of Pennsylvania · R37 · FY2019 · CA
Regulation of p53 by TAF1
$368,125Xuan Liu · University Of California Riverside · R01 · FY2017 · CA
Molecular mechanisms for bone marrow failure and clonal progression during the innate immune response in Fanconi Anemia
$368,096Elizabeth Ann Eklund · Northwestern University At Chicago · R01 · FY2019 · DK
Overcoming primary and secondary resistance in wild-type BRAF melanoma
$368,044Andrew E Aplin · Wistar Institute · P01 · FY2022 · CA
p53-mediated dead cell clearance in response to DNA damage and tumorigenesis
$368,043Sam W Lee · Massachusetts General Hospital · R01 · FY2016 · CA
p53-mediated dead cell clearance in response to DNA damage and tumorigenesis
$368,043Sam W Lee · Massachusetts General Hospital · R01 · FY2017 · CA
Biomaterials-based Germinal Center Niches for Understanding the B Cell Maturation and B cell receptor signaling
$367,982Ankur Singh · Georgia Institute Of Technology · R01 · FY2021 · AI
Project 2
$367,909Felicity Harper · Wayne State University · P20 · FY2022 · CA
DNA damaging therapy and immune response in small cell lung cancer subtypes
$367,887Lauren Averett Byers · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Regulatory Dendritic Cells in Cancer
$367,650Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2020 · CA
Regulatory Dendritic Cells in Cancer
$367,650Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2018 · CA
Regulatory Dendritic Cells in Cancer
$367,650Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA
Transcriptional and epigenetic mechanisms of immunotherapy resistance in melanoma
$367,559Kai W Wucherpfennig · Massachusetts General Hospital · P01 · FY2020 · CA